02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PEPPERMINT<br />

Scientific name: Mentha piperita<br />

Family: Labiatae<br />

Trade <strong>and</strong> other common names: Aludrox; br<strong>and</strong>y mint;<br />

Colpermin; Enteroplant (peppermint <strong>and</strong> caraway oils); menthol;<br />

PCC<br />

Category: Analgesic; Carminative; Vasodilator, peripheral<br />

Purported indications <strong>and</strong> other uses: Dyspepsia, regress<br />

pancreatic, mammary, <strong>and</strong> liver tumors, irritable bowel<br />

syndrome, colonic spasm, colic, nausea, vomiting, biliary<br />

disorders, common cold, dysmenorrhoea, anxiolytic. Topical:<br />

pain, itching, inflammations, headaches, toothache, pruritus,<br />

urticaria, mosquito repellant. Vapor: bronchial catarrh, fever,<br />

influenza. Flavoring, cosmetics, toothpaste, mouthwash<br />

Half-life: N/A<br />

Clinically important, potentially hazardous interactions<br />

with: cisapride<br />

Reactions<br />

Skin<br />

Adverse effects (sic)<br />

(1999): Madisch A+, Arzneimittelforschung 49(11), 925<br />

(1996): May B+, Arzneimittelforschung 46(12), 1149<br />

Allergic reactions (sic)<br />

Burning (anal)<br />

(1987): Weston CF, Postgrad Med J 63(742), 717<br />

Dermatitis<br />

(2002): Schempp CM+, Hautarzt 53(2), 93<br />

(1994): Wilkinson SM+, Contact Dermatitis 30(1), 42<br />

(1984): Mooller NE+, Acta Pharmacol Toxicol (Copenh)<br />

55(2), 139 (occupational)<br />

Lichenoid eruption<br />

(1995): Morton CA+, Contact Dermatitis 32(5), 281<br />

Perioral dermatitis<br />

(1995): Sainio EL+, Contact Dermatitis 33(2), 100<br />

Rash (sic)<br />

(1997): Liu JH+, J Gastroenterol 32(6), 765<br />

Sensitivity<br />

(2001): Nair B, Int J Toxicol 20, 61<br />

(1995): Morton CA+, Contact Dermatitis 32(5), 281<br />

Mucosal<br />

Burning mouth syndrome<br />

(1995): Morton CA+, Contact Dermatitis 32(5), 281<br />

Cheilitis<br />

(1995): Sainio EL+, Contact Dermatitis 33(2), 100<br />

(1984): Hausen BM, Dtsch Med Wochenschr 109(8), 300<br />

Gingivitis<br />

(1995): Sainio EL+, Contact Dermatitis 33(2), 100<br />

Glossitis<br />

(1995): Sainio EL+, Contact Dermatitis 33(2), 100<br />

Oral ulceration<br />

(1999): Moghadam BK+, Cutis 64(2), 131 (mouthwash abuse)<br />

(1995): Morton CA+, Contact Dermatitis 32(5), 281<br />

Stomatitis<br />

(1995): Rogers SN+, Dent Update 22(1), 36<br />

(1995): Sainio EL+, Contact Dermatitis 33(2), 100<br />

Other<br />

Hypersensitivity<br />

(1995): Sainio EL+, Contact Dermatitis 33(2), 100<br />

Side effects (sic)<br />

(1998): Belanger JT, Altern Med Rev 3(6), 448<br />

(1982): Jaffe G+, JIntMedRes10(6), 437<br />

Toxicity (sic)<br />

(2001): Lazutka JR+, Food Chem Toxicol 39(5), 485<br />

PERFLUTREN<br />

Trade names: Definity (DuPont); Optison (Amersham)<br />

Indications: Echocardiogram imaging<br />

Category: Radiographic contrast medium<br />

Half-life: 1.3 minutes<br />

Reactions<br />

Skin<br />

Diaphoresis (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!